BioTheranostics Lands $32,000,000 New Funding Round

  • Feed Type
  • Date
    1/22/2016
  • Company Name
    BioTheranostics
  • Mailing Address
    9640 Towne Centre Dr. San Diego, CA 92121 USA
  • Company Description
    BioTheranostics, Inc. is a commercial-stage molecular diagnostics company that develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients.
  • Website
    http://www.biotheranostics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $32,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    This growth financing will allow bioTheranostics to build on the strong momentum the company has achieved in recent years.
  • M&A Terms
  • Venture Investor
    MVM Life Science Partners
  • Venture Investor
    Canepa Advanced Healthcare Fund
  • Venture Investor
    HealthQuest Capital

Trending on Xconomy